LIVE

MarketsZachXBT сообщил о взломе европейского финучреждения и краже более $133 млн с криптобирж TechThe Endlessly Meme-able Steve Kornacki Is Not a Meme Person BusinessAMA voices cannabis concerns to federal officials (Newsletter: November 3, 2026)MarketsLouisiana-Pacific beats top-line and bottom-line estimates; gives Q4 and updates FY26 outlook MarketsIDEAYA Biosciences GAAP EPS of -$1.22 misses by $0.03, revenue of $10.24M beats by $2.66M MarketsMichael Burry Boosts Bets on BYD, JD.com, and Sprouts; Retains Fiserv and PayPal - TipRanks MarketsGartner beats top-line and bottom-line estimates; updates FY26 outlook MarketsBall Corporation Non-GAAP EPS of $1.10 beats by $0.03, revenue of $4.19B beats by $410M LocalSullivan lawmakers to hire outside counsel following state supreme court ruling - Mid Hudson News MarketsLeidos beats Q3 earnings estimates, raises FY2026 EPS outlook MarketsDuPont raises 2026 earnings forecast after stronger Q3 performance MarketsPatria Investments DEPS of $0.30 beats by $0.02, revenue of $104.2M beats by $2.46M BusinessPie Medical anuncia los resultados del ensayo LIPSIA-STRATEGY en revascularización BusinessLIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization BusinessDie LIPSIA-STRATEGY-Studie belegt die Nichtunterlegenheit der CAAS-vFFR-gesteuerten Revaskularisierung gegenüber der auf einem Druckdraht basierenden FFR-Revaskularisierung BusinessL'essai LIPSIA-STRATEGY démontre la non-infériorité de la revascularisation guidée par CAAS vFFR par rapport à la revascularisation FFR basée sur le fil de pression.LocalUS Supreme Court to weigh Catholic preschools' challenge to LGBT protections - Reuters BusinessFallsview Arts Marks First Year with Grand Opening Exhibition and Ribbon Cutting BusinessLINC Shareholder Notice: Lincoln Educational Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 10 BusinessQFIN Shareholder Notice: Qfin Holdings Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 27 BusinessENSG Shareholder Notice: Ensign Group Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is December 7 BusinessFLNC Shareholder Notice: Fluence Energy Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 27 BusinessGIL Shareholder Notice: Gildan Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is December 14 BusinessFUN Shareholder Notice: Six Flags Under Investigation for Potential Securities Fraud over Alleged Misrepresentations to Investors BusinessPSNL Shareholder Notice: Personalis $16.25 per Share Merger Under Investigation on Behalf of ShareholdersTRENDING TICKERS: $CRWD $NTAP $EL $NIQ $GIL $IQMX $HIMS $ASTS $ROK $LAZ $QBTS $BULL $DUOL $LINC $CC $TMUS $APP $TENX $FLNC $BAC $BBNX $VEEV $LKQ $MRP $LDOS $FE $EG $YFOR $MSTR $FCELMarketsZachXBT сообщил о взломе европейского финучреждения и краже более $133 млн с криптобирж TechThe Endlessly Meme-able Steve Kornacki Is Not a Meme Person BusinessAMA voices cannabis concerns to federal officials (Newsletter: November 3, 2026)MarketsLouisiana-Pacific beats top-line and bottom-line estimates; gives Q4 and updates FY26 outlook MarketsIDEAYA Biosciences GAAP EPS of -$1.22 misses by $0.03, revenue of $10.24M beats by $2.66M MarketsMichael Burry Boosts Bets on BYD, JD.com, and Sprouts; Retains Fiserv and PayPal - TipRanks MarketsGartner beats top-line and bottom-line estimates; updates FY26 outlook MarketsBall Corporation Non-GAAP EPS of $1.10 beats by $0.03, revenue of $4.19B beats by $410M LocalSullivan lawmakers to hire outside counsel following state supreme court ruling - Mid Hudson News MarketsLeidos beats Q3 earnings estimates, raises FY2026 EPS outlook MarketsDuPont raises 2026 earnings forecast after stronger Q3 performance MarketsPatria Investments DEPS of $0.30 beats by $0.02, revenue of $104.2M beats by $2.46M BusinessPie Medical anuncia los resultados del ensayo LIPSIA-STRATEGY en revascularización BusinessLIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization BusinessDie LIPSIA-STRATEGY-Studie belegt die Nichtunterlegenheit der CAAS-vFFR-gesteuerten Revaskularisierung gegenüber der auf einem Druckdraht basierenden FFR-Revaskularisierung BusinessL'essai LIPSIA-STRATEGY démontre la non-infériorité de la revascularisation guidée par CAAS vFFR par rapport à la revascularisation FFR basée sur le fil de pression.LocalUS Supreme Court to weigh Catholic preschools' challenge to LGBT protections - Reuters BusinessFallsview Arts Marks First Year with Grand Opening Exhibition and Ribbon Cutting BusinessLINC Shareholder Notice: Lincoln Educational Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 10 BusinessQFIN Shareholder Notice: Qfin Holdings Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 27 BusinessENSG Shareholder Notice: Ensign Group Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is December 7 BusinessFLNC Shareholder Notice: Fluence Energy Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 27 BusinessGIL Shareholder Notice: Gildan Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is December 14 BusinessFUN Shareholder Notice: Six Flags Under Investigation for Potential Securities Fraud over Alleged Misrepresentations to Investors BusinessPSNL Shareholder Notice: Personalis $16.25 per Share Merger Under Investigation on Behalf of ShareholdersTRENDING TICKERS: $CRWD $NTAP $EL $NIQ $GIL $IQMX $HIMS $ASTS $ROK $LAZ $QBTS $BULL $DUOL $LINC $CC $TMUS $APP $TENX $FLNC $BAC $BBNX $VEEV $LKQ $MRP $LDOS $FE $EG $YFOR $MSTR $FCEL

Skip to content

31 Percent of Workers Would Switch Jobs for GLP-1 Coverage. Employers Are Starting to Notice

Source: Inc.com · Nov 03, 2026 10:00 UTC

The Quick Take

As GLP-1 use rises, coverage is becoming a powerful recruiting and retention tool, forcing employers to weigh drug costs against the price of losing talent.

Read the full story at Inc.com →

Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Inc.com.

Related

The Endlessly Meme-able Steve Kornacki Is Not a Meme Person

NBC’s go-to data guru also isn’t quite sure what a subreddit is.

WIRED · 6m ago

Broadcom denied names of cloud providers backing VMware merger challenge

EU court's confidentiality ruling clears a procedural hurdle, not the merits of CISPE's case against Commission approval

www.theregister.com - Articles · 18m ago

Apple @ Work Podcast: How rising Apple costs are reshaping the trade-in market

Apple @ Work is exclusively brought to you by Mosyle , the only Apple Unified Platform. Mosyle is the only solution that integrates in a single…

9to5Mac · 18m ago

The Susan Collins Effect

“Part of it is she’s an incumbent, and part of it is it’s an image that’s cultivated by her PR people and by the Maine media to give the impression that she’s…

Columbia Journalism Review · 18m ago